Market Closed -
Other stock markets
|
Pre-market 07:03:21 am | |||
0.6648 USD | -9.25% | 0.675 | +1.53% |
Chart calendar Citius Pharmaceuticals, Inc.
Upcoming events on Citius Pharmaceuticals, Inc.
Past events on Citius Pharmaceuticals, Inc.
2024-04-17 10:30 am | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
2024-04-09 03:30 pm | LD Micro Invitational Conference |
2024-03-13 01:45 pm | Sidoti Small Cap Conference |
2024-03-12 08:00 am | Annual General Meeting |
2024-02-27 09:45 am | BIO CEO & Investor Conference |
2024-02-14 04:30 pm | Q1 2024 Earnings Release |
2024-01-02 08:30 am | Q4 2023 Earnings Release |
2023-12-04 12:00 am | Noble Capital Markets Emerging Growth Equity Conference |
2023-11-28 | GCFF Virtual Healthcare Conference |
2023-11-15 11:30 am | Sidoti Microcap Virtual Conference |
2023-10-19 02:30 pm | ThinkEquity Conference |
2023-10-12 01:30 pm | Dawson James Small Cap Growth Conference |
2023-09-20 02:30 pm | Sidoti Small Cap Conference |
2023-09-11 02:00 pm | H.C. Wainwright Global Investment Conference |
2023-08-14 04:15 pm | Q3 2023 Earnings Release |
2023-06-21 01:00 pm | Maxim Group Virtual Healthcare Conference |
2023-03-11 | Roth Conference |
2023-02-10 04:30 pm | Q1 2023 Earnings Release |
2023-02-06 | Annual General Meeting |
2023-01-18 10:45 am | Sidoti Micro-Cap Virtual Conference |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -15,6 -15,9 1.9% | -17,7 -18,8 5.79% | -23,5 -24,9 5.54% | -33,3 -34,5 3.48% | -36,7 -35,6 -3.16% | -36,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -23,1 -24,7 6.57% | -33,1 -34,4 3.8% | -32,0 -31,1 -2.94% | -36,5 |
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -24,5 -24,7 0.69% | -33,6 -34,4 2.13% | -33,7 -31,6 -6.53% | -36,6 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -0,23 -0,23 0% | -0,23 -0,24 4.17% | -0,22 -0,21 -4.76% | -0,22 |
Announcement Date | 16/12/19 | 16/12/20 | 15/12/21 | 22/12/22 | 29/12/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 10,6 | 11,0 |
EBIT Million USD | Released Forecast Spread | -9,26 -8,20 -12.92% | -7,59 -10,5 27.89% | -8,92 -8,99 0.77% | -7,55 -8,75 13.74% | -10,7 -7,54 -41.8% | -8,67 -10,7 18.8% | -10,1 -8,95 -13.13% | -8,31 | -8,53 | -8,73 | ||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,23 -8,20 -12.5% | -7,56 -10,5 28.17% | -8,86 -8,99 1.36% | -7,41 -8,72 14.99% | -10,4 -7,49 -38.56% | -8,34 -10,6 21.66% | -9,80 -8,89 -10.28% | -8,31 | -8,53 | -8,73 | ||||
Net income Million USD | Released Forecast Spread | -9,23 -8,20 -12.5% | -7,56 -10,5 28.17% | -8,86 -8,99 1.36% | -7,99 -8,72 8.38% | -3,59 | -10,5 -7,54 -39.55% | -8,48 -10,7 20.68% | -11,1 -8,97 -23.76% | -8,31 | -8,53 | -8,73 | |||
EPS USD | Released Forecast Spread | -0,06 -0,06 0% | -0,05 -0,07 28.57% | -0,06 -0,06 0% | -0,05 -0,06 16.67% | -0,02 | -0,07 -0,05 -40% | -0,06 -0,07 14.29% | -0,07 -0,06 -16.67% | -0,06 | -0,06 | -0,05 | -0,05 | ||
Announcement Date | 10/02/22 | 12/05/22 | 11/08/22 | 22/12/22 | 10/02/23 | 12/05/23 | 14/08/23 | 29/12/23 | 14/02/24 | - | - | - | - | - |
Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Citius Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CTXR Stock
- Calendar Citius Pharmaceuticals, Inc.